SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rosetta Genomics (ROSG) - microRNA
An SI Board Since July 2007
Posts SubjectMarks Bans Symbol
58 8 0 ROSG
Emcee:  Microcap Analyst Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
33<i>There is a fecal alternative with the exas test if you don't mind rSteve Lokness-1/17/2009
32There is a fecal alternative with the exas test if you don't mind reaching irkrw-1/17/2009
31I can think of several suitable punishments for a doc who gave me a colonoscopy nigel bates-1/17/2009
30<i>Colonoscopies are the bread and butter for GI docs. I doubt a GI doc woSteve Lokness-1/17/2009
29Colonoscopies are the bread and butter for GI docs. I doubt a GI doc would mentirkrw-1/17/2009
28Tuck; <i> Fluffy PR.</i> What makes you say that? I reread it thinSteve Lokness-1/17/2009
27I don't disagree. OTOH, such a test is going to be a lot more fun than a conigel bates-1/17/2009
26Methinks that 72% specificity number is going to have to show a lot of improvemetuck-1/16/2009
25Rosetta Genomics and Collaborators Unveil Colon Cancer Screening Diagnostic; Idenigel bates-1/16/2009
24<b>Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pidos-1/8/2009
23Third diagnostic test miRview(TM) meso, is available. finance.yahoo.comidos-1/6/2009
22ROSG also said it is looking for a partner instead of its former direct sales moidos-12/23/2008
21ROSG announced today the commercial availability of its second diagnostic test, idos-12/22/2008
20Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Binigel bates-10/27/2008
19<b>MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Iidos-9/18/2008
18Cross posting your link: plosone.org Circulating nucleic acids (CNAs) offer uninigel bates-9/6/2008
17Rosetta Genomics, Ltd. (NASDQ: ROSG) announces today that the first molecular teidos-7/23/2008
16recent news 06/11/08 Rosetta Genomics Executes Binding Term Sheet to Acquire U.Mike McFarland-6/12/2008
15ROSG and Columbia University Medical Center filed with the New York State Departidos-4/3/2008
14FYI just in ----Sunday reuters.com Test Tells Source of Mystery CancersMJ-3/23/2008
13Rosetta is up 77 cents as of 11 a.m.despite all of the negative news about the MJ-3/17/2008
12Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-basebob zagorin-12/13/2007
11Rosetta Genomics Strengthens Senior Management in Preparation for its First Commbob zagorin-12/3/2007
10UC Davis Researchers Identify A Cellular Pathway That Makes Prostate Cancer Fatabob zagorin-11/22/2007
9Collins Stewart: Rosetta launches on schedule "As the microRNA field increabob zagorin-11/13/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News